Event Calendar

Saturday, May 7, 2022

Cardiac Amyloidosis in Latin America: Current Situation and Perspectives

Date(s): May 7, 2022

Time: 9:30 AM  EST - 11:00 AM  EST

Join us for the Cardiac Amyloidosis in Latin America: Current Situation and Perspectives webinar to be conducted in Spanish (with slides in English) on Saturday, May 7 at 10:30 am (Brazil, Argentina, Uruguay) / 8:30 am CDT (Mexico) / 9:30 am EDT (Boston, USA).

Leading experts will provide the fundamental concepts allowing healthcare providers (HCPs) to accelerate disease awareness, timely testing, and initiation of targeted transthyretin (ATTR) amyloidosis therapies. The webinar will also provide insights to support and expand development of amyloidosis programs within Latin America.

Participants will receive a lesson book providing important resources to support this effort and a program evaluation to identify ongoing educational needs. 
 
AGENDA and FACULTY

Moderators:
Fernando Mut, MD, FASNC, Hospital Italiano (Uruguay)
Gabriel Grossman, MD, PhD, FASNC, Hospital Moinhos de Vento (Brazil) 
10:30 am Welcome and Introduction Fernando Mut, MD, FASNC, Hospital Italiano (Uruguay) and
Gabriel Grossman, MD, PhD, FASNC, Hospital Moinhos de Vento (Brazil) 
10:35 am AMILO LATAM Group Survey Results Isabel Carvajal, MD, (México)
Instituto Nacional de Cardiologia Ignacio Chavez 
10:50 am Epidemiology of Cardiac Amyloidosis in
Latin America: Opportunities to Improve
Diagnosis
Juan Erriest, MD (Argentina)
Hospital Italiano de La Plata
11:05 am Role of Nuclear Cardiology in Cardiac Amyloidosis 
Diagnosis – What is Possible in Latin America
Amalia Peix, MD, PhD (Cuba)
Instituto de cardiología y cirugía cardiovascular de la Habana
11:20 am Cardiac Amyloidosis Diagnosis Flowchart
– Integration of Methods
Marcelo Di Carli, MD, MASNC (USA/Argentina)
Brigham and Women's Hospital, Harvard Medical School
11:40 am Discussion and Questions Faculty
 


Cardiac Amyloidosis in Latin America is being organized by the Latin American Project on Cardiac Amyloidosis (AMILO LATAM) as part of the Reaching Across Latin America educational initiative designed to address ongoing knowledge, competence, and performance among HCPs across twenty countries in Latin America to enhance their skills for diagnosing and managing patients with transthyretin (ATTR) amyloidosis with the goal of improving long-term patient outcomes.




Change Category: